Institute for Stem Cell & Regenerative Medicine

at the University of Washington


All activities of the Institute will be imbued with an expectation of adhering to the highest standards of ethics, which will be formalized by having noted bioethicists involved in all stages of Institute design, operations, and oversight. Thus there will be formal training in bioethics before research and training commences, and monitoring procedures thereafter to insure compliance. The Institute has normal oversight and transparency in accordance with University policies.

Oversight Of The Team

Drs. Moon, Blau and Murry are the internationally recognized researchers who are responsible for planning, oversight, and the scientific and medical goals of ISCRM. They report to the office of the Dean of the School of Medicine, as well as an oversight committee, chaired by William Catterall, the Chair of the Department of Pharmacolgy. This advisory board includes internationally recognized scientists, Department Chairs and meets on anĀ annual basis.

Embryonic Stem Cell Research Oversight

The University of Washington (UW) established the Embryonic Stem Cell Research Oversight Committee (ESCRO), which exists to review and approve research involving human embryonic stem cells (hESC). The ESCRO Committee review ensures that both institutional and public concerns regarding sensitive ethical, legal, scientific, and policy issues unique to hESC research are addressed. For more information please visit theĀ ESCRO website.